IQTIN
LIVE

Serial Number

97160162

Owner

System Biologie AG

Attorney

Erik M. Pelton

First Use Date

Dec 22, 2022

Filing Date

Dec 7, 2021

Add to watchlist:

No watchlists yet
View on USPTO

IQTIN Trademark

Serial Number: 97160162 • Registration: 8253890

IQTIN is a trademark filed by System Biologie AG on December 7, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

System Biologie AG (21 trademarks)

Wollerau 8832 , CH

Entity Type: 03

Trademark Details

Filing Date

December 7, 2021

Registration Date

May 12, 2026

First Use Anywhere

December 22, 2022

First Use in Commerce

December 22, 2022

Published for Opposition

April 25, 2023

Goods & Services

Dietary supplements; Anti-inflammatories; Anti-inflammatory gels; Anti-inflammatory preparations; Veterinary preparations, namely, antioxidants; Central nervous system stimulants; Extracts of medicinal herbs; Extracts of medicinal plants; Herbal compounds, namely, herbal supplements; Herbal supplements; Immunostimulants; Immunomodulators; Medicated food supplements; Medicinal herbs; Medicinal drinks; Medicines for humans, namely, neurodegenerative and Inflammageing medicines; Medicine for neurodegenerative, epigenetic, and inflammation disorders; Medicinal preparations and substances for neurodegenerative and epigenetic disorders; Nutraceutical preparations for therapeutic or medical purposes in the form of a dietary supplement; Nutraceuticals for therapeutic purposes for use as a dietary supplement; Pharmaceutical preparations for preparations for the prevention of diseases of the nervous system; Pharmaceutical preparations for the prevention of diseases of the metabolic system; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of diseases of the endocrine system; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of Alzheimer's, Parkinson's, Dementia and inflammatory diseases; Phytotherapy preparations for medical purposes; Plant and herb extracts for medicinal use; Plant extracts for pharmaceutical purposes; Dietary supplement drink mixes; Dietary supplemental drinks; Dietary supplements for humans; Dietetic beverages adapted for medical purposes; Dietetic food preparations adapted for medical use, namely dietetic beverages; Dietetic foods adapted for medical purposes; Dietetic substances, namely dietetic beverages adapted for medical use; Food supplements; Food supplements in liquid form; Liquid herbal supplements; Liquid vitamin supplements; Mineral nutritional supplements; Mineral food supplements; Nutritional supplements; Nutraceuticals for use as a dietary supplement; Nutraceutical preparations for humans, namely, nutraceuticals for use as a dietary supplements for promoting overall health

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 12, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 12, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 22, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 22, 2026 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 17, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 17, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 21, 2024 SUPC
USE AMENDMENT FILED
Jun 20, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 20, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 10, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 9, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 9, 2024 AITU
SOU EXTENSION 1 FILED
Dec 18, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 18, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 20, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 22, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 22, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 22, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 22, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 20, 2023 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Mar 16, 2023 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Mar 16, 2023 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Mar 16, 2023 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 15, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 29, 2022 GNFN
FINAL REFUSAL E-MAILED
Dec 29, 2022 GNFR
FINAL REFUSAL WRITTEN
Dec 29, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 28, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 28, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 28, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 16, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 16, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 16, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2021 NWOS
NEW APPLICATION ENTERED
Dec 10, 2021 NWAP